图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:JOURNAL OF RHEUMATOLOGY

ISSN:0315-162X
版本:SCI-CDE
出版频率:Monthly
出版社:J RHEUMATOL PUBL CO, 365 BLOOR ST E, STE 901, TORONTO, CANADA, ONTARIO, M4W 3L4
  出版社网址:http://jrheum.org/
期刊网址:http://jrheum.org/
影响因子:4.666
主题范畴:RHEUMATOLOGY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

The Journal of Rheumatology, 365 Bloor Street East, Suite 901, Toronto, ON Canada M4W 3L4. Articles, editorials, hypotheses, case reports of exceptional interest and letters will be accepted for publication on condition that they are submitted solely to this journal. Subject matter may relate to the broad field of rheumatology, rehabilitation medicine, immunology, infectious diseases or orthopedic subjects pertaining to the rheumatic diseases.


Instructions to Authors

Manuscripts and all other editorial communications addressed to the Editor of The Journal of Rheumatology should be submitted via our online submission system, available at the Manuscript Central website. To submit a new manuscript start your web browser and visit http://mc.manuscriptcentral.com/jrheum. Check online records for an existing account. If you are submitting for the first time, create a new account. Follow all online instructions. At the end of successful submission, a confirmation screen with manuscript number will appear and you will receive an E-mail acknowledging that the manuscript has been received. If this does not happen, please check your submission and/or contact our technical support staff at manuscripts@jrheum.com . Manuscript, figures, and tables should be submitted as separate files. You do not need to mail any copies.

Submission Guidelines

Articles, editorials, reviews, hypotheses, case reports of exceptional interest, images in rheumatology, and letters will be accepted for publication following successful review and on condition that they are submitted solely to this journal. Case reports should be submitted as letters to the Editor. Subject matter may relate to the broad field of rheumatology, rehabilitation medicine, immunology, infectious diseases or orthopedic subjects pertaining to the rheumatic diseases. Manuscripts containing original material are accepted for consideration with the understanding that neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted for publication elsewhere before appearing in The Journal. This restriction does not apply to abstracts or press reports published in connection with scientific meetings.

Conflict of Interest: The Journal asks authors of research articles to disclose at the time of submission any financial arrangement they may have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, the editors will usually discuss with the authors the manner in which such information is to be communicated to the reader.

Because the essence of editorials and reviews is selection and interpretation of the literature, The Journal expects that authors of such articles will disclose any financial interest in a company (or its competitor) that makes a product discussed in the article. Potential authors who have questions about these issues should contact the Editor.

The Journal of Rheumatology discourages submission of more than one article dealing with related aspects of the same study. If authors are aware of any published paper or other manuscript in preparation or submitted elsewhere or to The Journal related to the manuscript under consideration (e.g., another manuscript resulting from the same study), a copy of the related paper should be uploaded as a supplementary file with the paper submitted for publication.

Articles are considered only for exclusive publication in The Journal with the understanding that they have not been published elsewhere (in part or in full, in other words or in the same words in letter or article form, or otherwise), are not at the time of submission under consideration by another journal or other publication, and will not be submitted elsewhere unless rejected by The Journal of Rheumatology. If an author violates this requirement or engages in other similar misconduct, the Editor may, in addition to rejecting the manuscript, impose a moratorium on the acceptance of new manuscripts from the author and if the misconduct is deemed sufficiently serious, may refer the matter to the author's academic institution or hospital and/or the appropriate disciplinary body.

For articles reporting clinical trials, registration in an appropriate public registry before the start of patient enrollment is strongly encouraged. Authors of articles reporting registered trials should include the trial registration number in the Abstract and in the Materials and Methods sections of their manuscript. The registration number will be published in articles accepted for publication.


Preparation of Manuscripts

Manuscripts should be concise and typed double-spaced with liberal margins. Journal titles cited in the references must conform to the abbreviations used in Index Medicus and follow the style shown below. Manuscripts should be submitted online accompanied by a covering letter indicating that the final manuscript has been seen and approved by all the authors and that they have given necessary attention to ensure the integrity of the work. The covering letter should note the type of manuscript submitted (full-length article, brief communication, case report [in letter format], images in rheumatology, or letter to the editor). The manuscript, accompanying tables, and figures should be prepared for online submission and review using conventional software. Number each page, including tables and figure legends, in sequence. Organize the manuscript to include: Title Page, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgment, References, Tables, Figures, and Figure Legends. For full-length articles and brief communications submit a structured abstract of no more than 250 words and 100 words, respectively. Indicate the main sections of the manuscript by side headings. Use the Arabic numbering system throughout the manuscript except at the beginning of sentences. Check manuscripts carefully before submission. To aid in the review process, include the statistical worksheet (not for publication), if applicable. Because of increasing publication costs, present the message as concisely as possible. For example, the Discussion should not exceed half the length of the whole article (preferably a third). Authors are encouraged to suggest the names of 3 or 4 persons who might be considered suitable reviewers of their work.

Brief communications are short investigative papers and reports organized in the same manner as full-length manuscripts, but which contain 1000 words or less, with no more than 3 figures or tables, and up to 15 references.

Case Reports are abbreviated case descriptions of exceptional clinical findings and clinical course, and should be submitted in the format of letters to the Editor (see below).

Editorials and review articles are usually solicited by the editors, but unsolicited material is also considered. Before submitting an editorial or a review, send a brief summary to the editor. Manuscripts on novel topics of interest will be recommended for submission and peer-review. Editorials and review articles on rheumatologic aspects of clinical practice, clinical therapeutics, current concepts, drug therapy, and mechanisms of disease are considered. Editorials are up to 1500 words, with up to 2 figures/ tables (total) and 20 references. Reviews are up to 3000 words, with a maximum of 4 figures/tables (total) and up to 50 references. These articles do not include an abstract.

Images in Rheumatology are abbreviated case descriptions of abstract length (about 250 words and 3 to 5 references) that feature exceptional visual illustrations.

Correspondence in the form of a Letter to the Editor should not exceed 800 words, with a maximum of 10 references and no more than 2 figures (submitted per above guidelines) or tables; and no subdivision for an abstract, methods, or results. Letters should have no more than 4 authors.

Supplements. The Journal welcomes the opportunity to publish proceedings of significant symposia providing the material represents original work not previously published. Symposium organizers are urged to contact the Editor well in advance of the symposium date with a draft program. Faculty, subject matter, and editorial content are all subject to the approval of the editorial committee. Papers submitted to be published in the proceedings must conform to the style for supplements, which is available on request, before they will be considered for publication.

Details of Format and Organization

Title Page. Title page should be prepared in the following order:

  • Full title of manuscript, which should be concise but informative.

  • Complete given names and surnames of all authors, without degrees.

  • Structured abstract, 250 words and 100 words or less, briefly describing Objective, Methods, Results, Conclusion. This applies to original articles and brief communications, respectively.

  • Case reports should be submitted in the format of letters to the Editor.

  • Key Indexing Terms—must be MeSH terms; others will be rewritten by the Editor. No more than 6 terms.

  • Name of department(s) and institution(s) to which the work should be attributed.

  • The source(s) of support in the form of grants or industrial support.

  • Initials, surnames, appointments and highest academic degrees of all authors.

  • Name and address of author to whom requests for reprints should be made.

  • Name and address of author responsible for correspondence about the manuscript.

  • A short running footline of no more than 4 words.

Acknowledgment

Acknowledgment, if applicable, should be added at the end of the discussion of the paper and before the references. It should not acknowledge grant or industrial support for fellowship awards, all of which should appear on the title page.

Tables

Prepare each table on a separate page, double-spaced. Number tables consecutively and supply a brief legend for each. References cited only in tables should be numbered in the sequence established by identification in the text.

Figures

General requirements for preparation of artwork. Figures should be professionally drawn and photographed, with the critical area of radiographs or photomicrographs indicated. Figures and figure labeling should be prepared for sizing to a single or a double column of text without loss of information. Figure labeling should be sized in proportion to the rest of the figure. For publication, figures are printed in black and white unless color is necessary for proper interpretation. Authors must bear all the costs of color printing. The publications office at your institution may be able to assist with preparation of artwork intended for publication.

Line drawings (charts, diagrams, etc.). When supplying diagrams or charts for the printed journal, authors should avoid use of solid and shaded background and fill effects. If necessary for interpretation, coarse stippling or hatching is recommended.

Half-tone figures (photographs, etc.). For online peer review, separate low-resolution figures are preferred. For acceptable formats see our online submission instructions. To meet requirements for both online review and print publication, authors should initially create half-tone figures of sufficient quality and resolution (300 dots per inch) to allow some loss of contrast and detail in printing and save figures in a standard graphic file format such as jpeg or tiff; authors should then save a second, low-resolution version for the submission/review process. The legend to each figure should be inserted in your manuscript following the references section, as well as with each separately uploaded figure. The final figures for publication should be supplied by uploading them as separate files to our online submission system on Scholar One. A second option for supplying final half-tone figures is to print them on high quality, glossy paper and mail them to our publication office. 

References

Number references consecutively in the order in which they are mentioned in the text. Identify references in text, tables, and legends by Arabic numerals (in parentheses). References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or illustration.

Use abbreviations for titles of medical journals that conform to those in Index Medicus. References style should conform to that suggested in "Uniform Requirements for Manuscripts Submitted to Medical Journals" (Annals of Internal Medicine 1997;126:36-47). Avoid using abstracts as references; "unpublished observations" and "personal communication" may not be used as references, although references to written, not verbal, communications may be inserted (in parentheses) in the text. Include among the references manuscripts accepted but not yet published; designate the journal followed by "in press." Information from manuscripts submitted but not yet accepted should be cited in the text as "unpublished observation" (in parentheses). Authors are responsible for the accuracy of references, which must be verified against original sources in the typescript and on the page proof. Examples of correct forms of references are given below.

Journal. Standard Journal Article (List all authors, but when 7 or more, list 6 and add "et al"): Soter NA, Wasserman SI, Austen KF. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Engl J Med 1976;294:687-90.

Journal Supplement. Dawkins RL, Garlepp MJ, McDonald BL, Williamson J, Zilko PJ, Carrano J. Myasthenia gravis and D-penicillamine. J Rheumatol 1981;8 Suppl 7:169-72.

Corporate Author. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended method for the determination of gamma-glutamyl-transferase in blood. Scand J Clin Lab Invest 1976;36:119-25. Editorial. Coffee drinking and cancer of the pancreas [editorial]. BMJ 1981;283:628.

Letter to the Editor. Gardner GC, Lawrence MK. Polyarteritis nodosa confined to calf muscles [letter]. Pedrol E, Garcia F, Casademont J [reply]. J Rheumatol 1993;20:908-9.

Abstract. Fischman SA, Joiner KA. Binding of the 3rd component of complement C3 by toxoplasma gondi [abstract]. Clin Res 1987; 35:475A.

Chapter in Book. Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr, Sodeman WA, editors. Pathologic physiology: mechanisms of disease. Philadelphia: WB Saunders; 1974:457-72.

Personal Author(s). Osler AG. Complement: mechanisms and functions. Englewood Cliffs: Prentice-Hall; 1976. Corporate Author. American Medical Association Department of Drugs. AMA Drug Evaluations. 3rd ed. Littleton: Publishing Sciences Group; 1977.

Editor, Compiler, Chair as Author. Rhodes AJ, Van Rooyen CE. Text of virology: for students and practitioners of medicine and the other health sciences. 5th ed. Baltimore: Williams & Wilkins; 1968.

Published Proceedings Paper. DuPont B. Bone marrow transplantation in severe combined immunodeficiency with an unrelated MLC compatible donor. In: White HJ, Smith R, editors. Proceedings of the Third Annual Meeting of the International Society for Experimental Hematology 1973, Oct 29-31; Houston: International Society for Experimental Hematology; 1974:44-6.

Agency Publication. National Center for Health Statistics. Acute conditions: incidence and associated disability. United States, July 1968-June 1969. Rockville: National Center for Health Statistics; 1972; DHEW publication no. (HSM)72-1036. (Vital and health statistics; series 10, no. 69).

Dissertation or Thesis. Cairns RB. Infrared spectroscopic studies of solid oxygen [dissertation]. Berkeley: University of California; 1965, 156 p.

Newspaper Article. Shaffer RA. Advances in chemistry are starting to unlock mysteries of the brain: discoveries could help cure alcoholism and insomnia, explain mental illness. How the messengers work. Wall Street Journal 1977 Aug 13; sect. A: 1 (col.1), 10(col.1) .

Magazine Article. Roueche B. Annals of medicine: the Santa Claus culture. The New Yorker 1971 Sep 4:66-81.

Article in a Foreign Language. Give exact title in original language, plus a brief summary of the title in English.

Serial on the Internet. Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 3 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm

Monograph on the Internet. Foley KM, Gelband H, editors. Improving palliative care for cancer [monograph on the Internet]. Washington: National Academy Press; 2001 [cited 2002 Jul 9]. Available from: http://www.nap.edu/books/0309074029/html/.

Homepage/Website. Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/.

Proofreading

Contributors are provided with page proofs and are asked to proofread them for typesetting errors. Important changes in data are allowed, but authors will be charged for excessive alterations in proof. Proofs must be returned within 48 hours.

Reprints

Reprints may be purchased by contributors when ordered before publication. An order form showing the costs of reprints will accompany the proofs.

Announcements. These should be sent to the Editor and must be received 3 months before publication.

Page charges. A $60 per page charge will be assessed for publication in The Journal of Rheumatology. Instructions for payment will be sent to authors along with the page proofs.

There is no charge for solicited articles or for correspondence commenting on published articles. In cases of extreme financial difficulty, consideration will be given to waiving page charges. Inquiries should be addressed to the managing editor.

Self-Archiving Policy for Publicly Funded Research. Authors of original research articles whose funding agency requires public access to the funded research may deposit their accepted manuscript in PDF format to institutional and/or centrally organized repositories (including PubMed Central), but must stipulate that public access to the manuscript be delayed until 12 months after first online publication in The Journal of Rheumatology. When depositing an accepted manuscript to a repository, authors shall include an acknowledgment line (see last entry below) and a hyperlink to the fully published version of the article posted on The Journal of Rheumatology website. This helps to ensure the article is correctly cited and will guarantee that the fully published and definitive version is readily available to those accessing the article from public repositories. The Journal authorizes deposit, in institutional and/or centrally organized repositories, of the accepted manuscript as prepared by the authors before publisher copy-editing and proof correction. For clarity the final published version of the article as it appears in The Journal of Rheumatology after copyediting and proof correction may not be deposited. Authors should include the following credit line when depositing their accepted manuscripts.
"This is a pre-copy-editing, author-produced PDF of an article accepted for publication in The Journal of Rheumatology following peer review. The definitive publisher-authenticated version [insert complete citation information here] is available online at: xxxxxxx [insert URL for the fully published article here]."

Full Release Publication Option. For those authors of original research articles whose funding agency requires public access to the funded research, The Journal of Rheumatology offers the option of Full Release publication. With this option, the author can elect to pay a fee to make the article available to non-subscribers from the time of first publication on The Journal of Rheumatology website. In contrast, articles published in the usual way, i.e., not as Full Release content, are subject to the usual subscription access controls. Full Release articles will be identified on our online table of contents. An article published under the Full Release option is subject to a publication charge of $3500. Regarding deposit requirement, such funded authors may also self-deposit the final peer reviewed version of the manuscript to a centrally organized repository, such as PubMedCentral.

Contact Information.

The Journal of Rheumatology, 365 Bloor Street East, Suite 901, Toronto, ON M4W 3L4, Canada. Tel: 416 967 5155; FAX: 416 967 7556; E-mail: jrheum@jrheum.com; Website: http//:www.jrheum.com
Editorial Board

Manuscripts on clinical subjects and original research are invited from scientists working in rheumatology and related fields, irrespective of their geographic location. The Journal will also consider the publication of symposia on topics of interest and new developments in the field of rheumatology, either in its regular issues or as supplements to the regular issue.

The Journal of Rheumatology is published monthly by The Journal of Rheumatology Publishing Company Limited. Contributions to The Journal should be submitted to

Duncan A. Gordon, The Editor,
The Journal of Rheumatology,
365 Bloor Street East, Suite 901,
Toronto, ON M4W 3L4 Canada

Subscription inquiries should be directed to the Subscription Manager, advertising inquiries to the Advertising Manager, and all other correspondence to Yvonne Pigott, Managing Editor. Our U.S. postal address is: The Journal of Rheumatology, 1051 Clinton Street, Buffalo, NY 14206-2823, USA. (If you are mailing within Canada, send correspondence to our Toronto address, above.)

Editorial and subscriptions - The Journal of Rheumatology
Telephone (416) 967-5155; Fax (416) 967-7556
Advertising - USA: Peter Palmer, Professional Media Group, Inc.,
Telephone (856) 589-5454; Fax (609) 582-7611
Advertising - Canada: Pat Tramley, JLS Media
Telephone (866) 426-9722; Fax (866) 426-4736

Microfilm and microfiche editions are available for purchase. Address orders to:

ProQuest Information and Learning
300 North Zeeb Rd.,
Ann Arbor, MI 48106-1346 USA



 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有